Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) Research & Development: 2018-2025

Historic Research & Development for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Evolus' Research & Development fell 11.58% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 6.54%. This contributed to the annual value of $9.2 million for FY2024, which is 39.90% up from last year.
  • Latest data reveals that Evolus reported Research & Development of $2.0 million as of Q3 2025, which was up 11.38% from $1.8 million recorded in Q2 2025.
  • Evolus' Research & Development's 5-year high stood at $2.4 million during Q4 2024, with a 5-year trough of $301,000 in Q3 2021.
  • Over the past 3 years, Evolus' median Research & Development value was $2.1 million (recorded in 2024), while the average stood at $2.0 million.
  • Within the past 5 years, the most significant YoY rise in Evolus' Research & Development was 357.14% (2022), while the steepest drop was 44.35% (2022).
  • Quarterly analysis of 5 years shows Evolus' Research & Development stood at $423,000 in 2021, then soared by 218.68% to $1.3 million in 2022, then surged by 76.56% to $2.4 million in 2023, then increased by 2.10% to $2.4 million in 2024, then fell by 11.58% to $2.0 million in 2025.
  • Its Research & Development stands at $2.0 million for Q3 2025, versus $1.8 million for Q2 2025 and $2.2 million for Q1 2025.